Article
A novel KCNV2 mutation in a patient taking hydroxychloroquine associated with cone dystrophy with supernormal rod response.
Ophthalmic genetics - 1 Aug 2021
Liu Pei-Kang, Ryu Joseph, Yeh Lung-Kun, Chen Kuan-Jen, Tsang Stephen H, Liu Laura, Wang Nan-Kai
Abstract excerpt
BACKGROUND: Cone dystrophy with supernormal rod response (CDSRR) is a rare inherited retinal degeneration. A patient superimposed with medical conditions requiring use of hydroxychloroquine (HCQ) may obscure accurate diagnosis of CDSRR. Herein, we report a referral case for HCQ retinopathy screening. Comprehensive ophthalmic examinations, however, guided the diagnosis of CDSRR from a novel mutation in potassium...
Topics
- Adult
- Antirheumatic Agents
- Consanguinity
- Electroretinography
- Female
- Frameshift Mutation
- Genetic Testing
- Humans
- Hydroxychloroquine
- Lupus Erythematosus, Systemic
- Male
